Navigation Links
Cmed Technology to Preview New Innovations to Speed and Streamline Electronic Trials at DIA Conference
Date:6/8/2011

NEW PROVIDENCE, N.J., June 8, 2011 /PRNewswire/ -- Cmed Technology, an innovative provider of eClinical technology, announced today it will preview its forthcoming Timaeus Guided Trial Builder product at this month's Drug Information Association (DIA) Annual Meeting in Chicago, IL. Guided Trial Builder will introduce an entirely different approach to simplify and streamline the startup of electronic trials. It expands on the Timaeus on-demand eClinical platform's history of harnessing innovation to empower clinical research teams to do more—in more places—with less time and effort.

(Logo: http://photos.prnewswire.com/prnh/20100707/NY31446LOGO)

Guided Trial Builder will enable non-programmers to rapidly build entire trials, including visit schedules, pages and edit checks. It automatically ensures adherence to standards and seamlessly validates the trial during the build process, eliminating the need for manual quality control (QC) and hand-off between teams. Adding Guided Trial Builder to Timaeus' on-demand deployment capabilities allows study teams to start new trials and perform mid-trial updates at the touch of a button—without downtime or site interruption. Cmed Technology is currently working with a Top 10 pharmaceutical company to quantify the time and efficiency improvements Guided Trial Builder will provide.

"Today, more than ever, speed is everything as pharmaceutical and biotech companies look for faster trial builds, earlier go-live dates and immediate access to clinical trial data," said Dr. David Connelly, CEO of Cmed. "Guided Trial Builder expands on our many years of work building eClinical technology that can rapidly respond to the needs of research organizations. Imagine the benefits of building and deploying entire study databases in days—rather than weeks or months."

Cmed Technology will highlight how

SOURCE Cmed Technology
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. VG Energys Lipid Enhancement Technology Independently Confirmed in First Phase of Testing for Potential Commercial Production of Biofuels
2. Reportlinker Adds Future of White Biotechnology in China
3. Asmacure Ltee Appoints Pharmaceutical and Biotechnology Industry Veteran Martin Driscoll as CEO
4. C3i Inc to Provide Full-Service Technology Support and Oracle Clinical, Oracle Remote Data Capture Business Process Outsourcing to XBiotech, Inc
5. New technology could inspire brain implant for detecting and treating seizures
6. Science & Technology News Service Expands Coverage
7. From seawater to freshwater with a nanotechnology filter
8. Enox Biopharma, Inc. Expands Its Technology to Cover the Wound Care Market
9. DNA Technology on the Menu in 11,000 U.S. Restaurants
10. Reportlinker Adds Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries
11. Lixte Biotechnology Holdings Announces New Appointment to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015   PureTech , a science and ... disruptive products and technologies in the healthcare sector, announced ... CEO and Member of the Board of Directors of ... "It,s has been a pleasure to know Chris for ... will be working together more closely now," said Dr. ...
(Date:2/26/2015)... 26, 2015 On behalf of biotech client ... Wilentz, Goldman & Spitzer, P.A. (Wilentz) secured a ... Genewiz Inc. in excess of $10 million. The jury ... secrets, and that it improperly hired one or more ... motions for judgment notwithstanding the verdict, a new trial, ...
(Date:2/26/2015)... , Feb. 26, 2015 /PRNewswire/ - SQI Diagnostics ... a life sciences company that develops and commercializes proprietary ... its financial and operational results for the fiscal first ... press release are in Canadian dollars (CAD), unless otherwise ... continued to win new business from our existing customers ...
(Date:2/26/2015)... Feb. 26, 2015   Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... President and Chief Executive Officer of Regulus, will present ... th Annual Healthcare Conference on Wednesday, March 4, ... held at the Boston Marriott Copley Place.  ...
Breaking Biology Technology:Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
... Inc. (Nasdaq: NXTM ), a leading manufacturer ... its financial results for the first quarter ended March ... opening of the financial markets.NxStage will also host a ... May 8, 2009 to discuss its first quarter financial ...
... General Meeting of Syngenta AG on 21 April 2009, ... Board of Directors. Shareholders approved a dividend of CHF ... increase of 25% over the previous year. Shareholders also ... 9,459,984.90 through the cancellation of 2,315,008 shares, which the ...
... and Webcast to FollowTHE WOODLANDS, Texas, April 21 ... release its first quarter 2009 financial results on Tuesday, ... Lexicon management will hold a conference call to discuss ... quarter 2009 at 11:00 a.m. Eastern Time on April ...
Cached Biology Technology:NxStage to Report First Quarter 2009 Financial Results 2Syngenta holds Annual General Meeting 2Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009 2
(Date:2/19/2015)... DUBLIN , Feb .19, 2015 Research ... announced the addition of the "Military Electro-Optical ... by Sensor Technology, by Platform - Forecast to ... The military electro-optical/infrared systems market is expected ... a CAGR of 7.71%. This report ...
(Date:2/12/2015)... Minn. , Feb. 12, 2015   ... company specializing in clinical study management systems, has ... Program , further distinguishing iMedNet ... Clinical Research Organizations (CROs) and healthcare consultants.  Building ... support, prospective customer referrals and numerous co-marketing opportunities), ...
(Date:2/10/2015)... WALTHAM, Mass., Feb. 10, 2015  Alere Inc. ... announced its financial results for the quarter ended ... Executive Officer and President of Alere said, "We ... refocussing Alere as the global leader in rapid ... closing the Alere Health divestiture in early January ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
... for the research community, including seasoned researchers and ... news, gain access to research and educational tools ... possibilities, as well as personalize their accounts to ... offers abstracts and selected articles from the information ...
... full of mutually beneficial arrangements between organismslike the ... But sometimes these blissful relationships have a dark ... an article for the May issue of The ... between ants and plants is a great example ...
... Va. -- Scientists at the Wake Forest University School ... Kingdom, and the Virginia Bioinformatics Institute at Virginia Tech ... biology map of iron metabolism. The team has put ... for the many steps and reactions that constitute iron ...
Cached Biology News:When industrious ants go too far 2Toward a systems biology map of iron metabolism 2Toward a systems biology map of iron metabolism 3
Form: Ready to use Applications: Immunohistology-frozen, Immunohistology-paraffin, Western Blot, ELISA...
EnzChek Ultra Xylanase Assay Kit *500 assays*...
Defender against cell death 1...
Mouse monoclonal [TONI-1] to Angiotensin II Type 1 Receptor (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 185 SwissProtID: P30556...
Biology Products: